DAVID PATZER: Open Payments
NPI 1376780841 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 25 payments from 13 companies in 2025. Trend: 2023 $1,343 · 2024 $849 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $93 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Neurocrine BioSciences, Inc. | 2 | $59 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| Noven Therapeutics, LLC | 2 | $43 |
| Indivior Inc. | 2 | $41 |
| Bausch Health US, LLC | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Alkermes, Inc. | 1 | $34 |
| ACADIA Pharmaceuticals Inc | 1 | $25 |
Products named: VRAYLAR, REXULTI, INGREZZA, Auvelity, Xelstrym, SUBLOCADE, APLENZIN, TRINTELLIX.
Industry payments across TN — which companies pay providers there.
